TÜV SÜD welcomes new transition periods
On 6 January 2023, the European Commission published a proposal to amend the Medical Device Regulation (MDR) and the In…
On 6 January 2023, the European Commission published a proposal to amend the Medical Device Regulation (MDR) and the In…
Poxel SA announces today, that it has raised EUR10 million ($13.5 million) through a Series B extension with the Large V…
Anergis, a company focusing on proprietary allergy vaccines, today reported immunology data from the Phase IIb study of…
. - Consolidated revenue up 167% in the first half-year - Consolidated loss reduced further due to higher revenue and…
The biopharmaceutical company Antisense Pharma GmbH announces that the US Food and Drug Administration (FDA) has granted…
At the international cancer congress ASCO 2011 in Chicago, USA, the biopharmaceutical company Antisense Pharma presented…
Antisense Pharma GmbH, a biopharmaceutical company headquartered in Germany, has announced the granting of patents for a…
The biopharmaceutical company Antisense Pharma today announced that the South Korean health agency KFDA as well as the T…
The biopharmaceutical company Antisense Pharma announced today that their international, randomized and active-controlle…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that dat…